Abdulla S - Search Results

1

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.

Abdulla S, Sagara I, Borrmann S, D'Alessandro U, González R, Hamel M, Ogutu B, Mårtensson A, Lyimo J, Maiga H, Sasi P, Nahum A, Bassat Q, Juma E, Otieno L, Björkman A, Beck HP, Andriano K, Cousin M, Lefèvre G, Ubben D, Premji Z. Abdulla S, et al. Lancet. 2008 Nov 22;372(9652):1819-27. doi: 10.1016/S0140-6736(08)61492-0. Epub 2008 Oct 14. Lancet. 2008. PMID: 18926569 Free article. Clinical Trial.

2

Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children.

Irion A, Felger I, Abdulla S, Smith T, Mull R, Tanner M, Hatz C, Beck HP. Irion A, et al. Among authors: abdulla s. Trop Med Int Health. 1998 Jun;3(6):490-7. doi: 10.1046/j.1365-3156.1998.00253.x. Trop Med Int Health. 1998. PMID: 9657512 Free article. Clinical Trial.

3

Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.

Hatz C, Abdulla S, Mull R, Schellenberg D, Gathmann I, Kibatala P, Beck HP, Tanner M, Royce C. Hatz C, et al. Among authors: abdulla s. Trop Med Int Health. 1998 Jun;3(6):498-504. doi: 10.1046/j.1365-3156.1998.00250.x. Trop Med Int Health. 1998. PMID: 9657513 Free article. Clinical Trial.

4

Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania.

Schellenberg JR, Abdulla S, Nathan R, Mukasa O, Marchant TJ, Kikumbih N, Mushi AK, Mponda H, Minja H, Mshinda H, Tanner M, Lengeler C. Schellenberg JR, et al. Among authors: abdulla s. Lancet. 2001 Apr 21;357(9264):1241-7. doi: 10.1016/S0140-6736(00)04404-4. Lancet. 2001. PMID: 11418148

5

Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies.

Mugittu K, Abdulla S, Falk N, Masanja H, Felger I, Mshinda H, Beck HP, Genton B. Mugittu K, et al. Among authors: abdulla s. Malar J. 2005 Nov 18;4:55. doi: 10.1186/1475-2875-4-55. Malar J. 2005. PMID: 16297234 Free PMC article.

6

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar.

Bhattarai A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, Khatib R, Al-Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Björkman A. Bhattarai A, et al. Among authors: abdulla s. PLoS Med. 2007 Nov 6;4(11):e309. doi: 10.1371/journal.pmed.0040309. PLoS Med. 2007. PMID: 17988171 Free PMC article.

7

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.

Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S. Kabanywanyi AM, et al. Among authors: abdulla s. Malar J. 2007 Nov 11;6:146. doi: 10.1186/1475-2875-6-146. Malar J. 2007. PMID: 17996121 Free PMC article. Clinical Trial.

8

The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.

Premji ZG, Abdulla S, Ogutu B, Ndong A, Falade CO, Sagara I, Mulure N, Nwaiwu O, Kokwaro G. Premji ZG, et al. Among authors: abdulla s. Malar J. 2008 Nov 25;7:244. doi: 10.1186/1475-2875-7-244. Malar J. 2008. PMID: 19032767 Free PMC article. Review.

9

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.

Abdulla S, Oberholzer R, Juma O, Kubhoja S, Machera F, Membi C, Omari S, Urassa A, Mshinda H, Jumanne A, Salim N, Shomari M, Aebi T, Schellenberg DM, Carter T, Villafana T, Demoitié MA, Dubois MC, Leach A, Lievens M, Vekemans J, Cohen J, Ballou WR, Tanner M. Abdulla S, et al. N Engl J Med. 2008 Dec 11;359(24):2533-44. doi: 10.1056/NEJMoa0807773. Epub 2008 Dec 8. N Engl J Med. 2008. PMID: 19064623 Free article. Clinical Trial.

10

Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.

Abdulla S, Sagara I. Abdulla S, et al. Malar J. 2009 Oct 12;8 Suppl 1(Suppl 1):S7. doi: 10.1186/1475-2875-8-S1-S7. Malar J. 2009. PMID: 19818174 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

435 results

Search Page